meta_analysis
    2019
    High Quality

    Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis

    Hu Y, Hu FB, Manson JE

    Published in Journal of the American Heart Association

    Methodology

    Meta-analysis of 13 randomized trials of marine omega-3 supplementation and cardiovascular outcomes.

    Key Findings

    Omega-3 supplementation was associated with modest reductions in myocardial infarction (8%) and CHD death (8%), with dose-response.

    Conclusions

    Marine omega-3 supplementation modestly lowers coronary risk.

    Limitations

    Heterogeneous doses and formulations; REDUCE-IT dominates effect size.

    Supplements Studied

    Marine omega-3 supplementation was associated with lowered risk of myocardial infarction and coronary heart disease death.

    Outcomes Measured

    Cardiovascular Risk Reduction

    Marine omega-3 supplementation was associated with lowered risk of myocardial infarction and coronary heart disease death.

    Related Health Concerns

    Coronary Artery Disease
    Cardiovascular Disease

    Study Details

    Year:2019
    Sample Size:127,477
    Quality Score:9/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.